Chul Won Jung

7.6k total citations
245 papers, 5.0k citations indexed

About

Chul Won Jung is a scholar working on Hematology, Genetics and Oncology. According to data from OpenAlex, Chul Won Jung has authored 245 papers receiving a total of 5.0k indexed citations (citations by other indexed papers that have themselves been cited), including 135 papers in Hematology, 69 papers in Genetics and 69 papers in Oncology. Recurrent topics in Chul Won Jung's work include Acute Myeloid Leukemia Research (66 papers), Chronic Myeloid Leukemia Treatments (47 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (32 papers). Chul Won Jung is often cited by papers focused on Acute Myeloid Leukemia Research (66 papers), Chronic Myeloid Leukemia Treatments (47 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (32 papers). Chul Won Jung collaborates with scholars based in South Korea, United States and Canada. Chul Won Jung's co-authors include Kihyun Kım, Won Seog Kim, Keunchil Park, Won Ki Kang, Jun Ho Jang, Young‐Hyuck Im, Jeeyun Lee, Joon Oh Park, Seok Jin Kim and Young Hyeh Ko and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Chul Won Jung

232 papers receiving 4.9k citations

Peers

Countries citing papers authored by Chul Won Jung

Since Specialization

Citations

This map shows the geographic impact of Chul Won Jung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chul Won Jung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chul Won Jung more than expected).

Fields of papers citing papers by Chul Won Jung

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chul Won Jung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chul Won Jung. The network helps show where Chul Won Jung may publish in the future.

Co-authorship network of co-authors of Chul Won Jung

This figure shows the co-authorship network connecting the top 25 collaborators of Chul Won Jung. A scholar is included among the top collaborators of Chul Won Jung based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chul Won Jung. Chul Won Jung is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Assessing the clinical applicability of dimensionality reduction algorithms in flow cytometry for hematologic malignancies 2025 ·Clinical Chemistry and Laboratory Medicine (CCLM) ·(unknown), (unknown), Boram Kim, Hee Young Ju, Keon Hee Yoo, Chul Won Jung, Hee‐Jin Kim, Hyun‐Young Kim, (unknown), (unknown)	0
2	QuantiFERON monitor predicts early cytomegalovirus infection and viral burden in allogeneic hematopoietic stem cell transplantation 2024 ·Transplant Infectious Disease ·(unknown), Sunghwan Shin, Sooin Choi, (unknown), Kihyun Kım, (unknown), Won Seog Kim, Chul Won Jung, Eun‐Suk Kang	2
3	Rare Case of Germline GATA2‐Deficiency With Merkel Cell Carcinoma and Acute Myeloid Leukemia 2024 ·Cancer Reports ·(unknown), (unknown), (unknown), Junhun Cho, Chul Won Jung, Hee‐Jin Kim, Hyun‐Young Kim, (unknown), (unknown)	0
4	Clinical Significance of bZIP In-Frame CEBPA-Mutated Normal Karyotype Acute Myeloid Leukemia 2023 ·Cancer Research and Treatment ·(unknown), Tae‐Hyung Kim, Mihee Kim, Ga‐Young Song, Sunghoon Jung, Deok‐Hwan Yang, Je‐Jung Lee, Mi Yeon Kim, Chul Won Jung, Jun‐Ho Jang, Hee‐Je Kim, Joon Ho Moon, Sang Kyun Sohn, Jong-Ho Won, Sung‐Hyun Kim, Hyeoung‐Joon Kim, Jae‐Sook Ahn, Dennis Dong Hwan Kim	3
5	Effects of CALR-Mutant Type and Burden on the Phenotype of Myeloproliferative Neoplasms 2022 ·Diagnostics ·Hyun‐Young Kim, (unknown), Jun Ho Jang, Chul Won Jung, Sun‐Hee Kim, Hee‐Jin Kim	6
6	Correlation between peripheral blood automated hematopoietic progenitor cell counts and flow cytometric CD34⁺ cell counts differs according to diagnosis in patients undergoing autologous peripheral blood stem cell transplantation 2021 ·Journal of Clinical Apheresis ·Sangmi Kim, Hyun‐Young Kim, Seok Jin Kim, Jun Ho Jang, Kihyun Kım, Won Seog Kim, Chul Won Jung, Duck Cho, Eun‐Suk Kang	4
7	Is the New Interferon-Gamma Releasing Assay Beneficial for the Diagnosis of Latent and Active Mycobacterium tuberculosis Infections in Tertiary Care Setting? 2021 ·Journal of Clinical Medicine ·(unknown), Byung Woo Jhun, (unknown), (unknown), Hee Jae Huh, Chul Won Jung, Kihyun Kım, Jae Berm Park, Dae Joong Kim, Wooseong Huh, Hye Ryoun Jang, Young‐Ho Kim, Sung Noh Hong, Doo Ryeon Chung, Eun‐Suk Kang	10
8	Complementary Use of Presepsin with the Sepsis-3 Criteria Improved Identification of High-Risk Patients with Suspected Sepsis 2021 ·Biomedicines ·Jong Eun Park, (unknown), (unknown), Chi-Min Park, Chul Won Jung, Myung‐Ju Ahn, Hyung‐Doo Park, Sung Yeon Hwang, Tae Gun Shin, Eun‐Suk Kang	9
9	Optimizing Preparative Regimen for Umbilical Cord Blood Transplantation in Adult Acute Leukemia Patients: Acute Lymphoblastic Leukemia Requires Myeloablative Conditioning but Not Acute Myeloid Leukemia 2020 ·Journal of Clinical Medicine ·Ja Min Byun, Junshik Hong, Doyeun Oh, Ho‐Young Yhim, Young Rok, Joon Seong Park, Chul Won Jung, Deok‐Hwan Yang, Jong-Ho Won, Mark Hong Lee, Joon Ho Moon, Yeung‐Chul Mun, Deog‐Yeon Jo, Jae Joon Han, Je‐Hwan Lee, (unknown), Jae Hoon Lee, Junglim Lee, Sung‐Soo Yoon	0
10	Antifungal prophylaxis with posaconazole tablet and oral suspension in patients with haematologic malignancy: Therapeutic drug monitoring, efficacy and risk factors for the suboptimal level 2019 ·Mycoses ·(unknown), Cheol‐In Kang, Si‐Ho Kim, Kyungmin Huh, Sun Young Cho, Doo Ryeon Chung, Soo‐Youn Lee, Chul Won Jung, Kyong Ran Peck	24
11	Intravenous Iron Supplementation Alone for Treatment of Anemia in Cancer Patients 2017 ·Blood ·Silvia Park, Chul Won Jung, Jun Ho Jang	1
12	Morphological Subtype According to the FAB Classification Correlates with Molecular Subtype Using Genomic Risk Classification Based on Somatic Mutation Profiles in Normal Karyotype AML 2017 ·Blood ·Jae‐Sook Ahn, Hyeoung‐Joon Kim, Yeo‐Kyeoung Kim, (unknown), Seo-Yeon Ahn, Sung‐Hoon Jung, Deok‐Hwan Yang, Je‐Jung Lee, Seung-Hyun Choi, Chul Won Jung, Jun‐Ho Jang, Hee‐Je Kim, Joon Ho Moon, Sang Kyun Sohn, (unknown), Jong-Ho Won, Sung‐Hyun Kim, Tae-Hyung Kim, Zhaolei Zhang, Dennis Kim	1
13	Hematologic Response to Romiplostim Treatment Is Associated with Stimulation of Primitive Stem/Progenitor Cells and Stromal Cells in Patients with Aplastic Anemia Refractory to Immunosuppressive Therapy: A 2-Year Interim Exploratory Analysis of a Phase 2 Clinical Trial 2017 ·Blood ·Jong‐Wook Lee, Sung‐Eun Lee, Chul Won Jung, Silvia Park, Jina Kim, Il‐Hoan Oh, Jun Ho Jang	3
14	Survey of Qol (quality of life) on Patients Receiving Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia: Korean CML Working Party Group 2015 ·Blood ·Kyoung Ha Kim, Dae‐Young Kim, Sung‐Hyun Kim, Yeo‐Kyeoung Kim, Inho Kim, Hee‐Jin Kim, Sang Kyun Sohn, (unknown), June‐Won Cheong, Chul Won Jung, Young‐Uk Cho	1
15	Retrospective multicenter study on the development of peripheral lymphocytosis following second‐line dasatinib therapy for chronic myeloid leukemia 2011 ·American Journal of Hematology ·Su Jin Lee, Chul Won Jung, Dae‐Young Kim, Kyoo‐Hyung Lee, Sang Kyun Sohn, Jae‐Yong Kwak, Hyeoung‐Joon Kim, In Ho Kim, Seonyang Park, Dong Hwan Kim	23
16	Comprehensive evaluation of time‐to‐response parameter as a predictor of treatment failure following imatinib therapy in chronic phase chronic myeloid leukemia: Which parameter at which time‐point does matter? 2010 ·American Journal of Hematology ·Dong Hwan Kim, (unknown), Chul Won Jung, Suzanne Kamel‐Reid, Jerald P. Radich, Jeffrey H. Lipton	9
17	BCL2 gene polymorphism could predict the treatment outcomes in acute myeloid leukemia patients 2009 ·Leukemia Research ·Joon Ho Moon, Sang Kyun Sohn, Myung-Hoon Lee, Jun Ho Jang, Kihyun Kım, Chul Won Jung, Dong Hwan Kim	31
18	Study to Develop the Instrument of Pattern Identification for Hwa-byung 2008 ·Journal of Physiology & Pathology in Korean Medicine ·(unknown), Seok Hwan Kim, (unknown), Chul Won Jung	17
19	The impact of Epstein-Barr virus status on clinical outcome in diffuse large B-cell lymphoma 2007 ·Blood ·Sarah Park, Jeeyun Lee, Young Hyeh Ko, Arum Han, Hyun Jung Jun, Sang Chul Lee, In Gyu Hwang, Winnie Yeo, Jin Seok Ahn, Chul Won Jung, Kihyun Kım, Yong Chan Ahn, Won Ki Kang, Keunchil Park, Won Seog Kim	242
20	A Case of Anaplastic Myeloma: Role of Immunophenotyping in Initial Diagnosis 2004 ·The Korean Journal of Laboratory Medicine ·Hyun‐Kyung Park, Hee‐Jin Kim, (unknown), (unknown), Chul Won Jung, Hyun Soo Kim, Sun Hee Kim	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact